These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33941126)

  • 1. Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway.
    Bjerke RD; Laake I; Feiring B; Aamodt G; Trogstad L
    BMC Public Health; 2021 May; 21(1):854. PubMed ID: 33941126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway.
    Feiring B; Laake I; Molden T; Cappelen I; Håberg SE; Magnus P; Steingrímsdóttir ÓA; Strand BH; Stålcrantz J; Trogstad L
    BMJ Open; 2015 May; 5(5):e006422. PubMed ID: 25991445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.
    Feiring B; Laake I; Bakken IJ; Greve-Isdahl M; Wyller VB; Håberg SE; Magnus P; Trogstad L
    Vaccine; 2017 Jul; 35(33):4203-4212. PubMed ID: 28648542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study.
    Wang J; Ploner A; Sparén P; Lepp T; Roth A; Arnheim-Dahlström L; Sundström K
    Prev Med; 2019 Mar; 120():26-33. PubMed ID: 30593796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.
    Hansen BT; Campbell S; Burger E; Nygård M
    Prev Med; 2015 Aug; 77():4-10. PubMed ID: 25944266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mental illness and neurodevelopmental conditions in human papillomavirus vaccination uptake within the Swedish school-based vaccination programme: a population-based cohort study.
    Hu K; Barker MM; Herweijer E; Wang J; Feldman AL; Lu D; Valdimarsdóttir U; Sundström K; Fang F
    Lancet Public Health; 2024 Sep; 9(9):e674-e683. PubMed ID: 39214636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic predictors of human papillomavirus vaccination among girls in the Danish childhood immunization program.
    Slåttelid Schreiber SM; Juul KE; Dehlendorff C; Kjær SK
    J Adolesc Health; 2015 Apr; 56(4):402-7. PubMed ID: 25659994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway.
    Feiring B; Laake I; Christiansen IK; Hansen M; Stålcrantz J; Ambur OH; Magnus P; Jonassen CM; Trogstad L
    J Infect Dis; 2018 Nov; 218(12):1900-1910. PubMed ID: 30010913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing uptake of HPV vaccination among girls in Germany.
    Schülein S; Taylor KJ; König J; Claus M; Blettner M; Klug SJ
    BMC Public Health; 2016 Sep; 16():995. PubMed ID: 27645711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
    Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
    Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians.
    Santos ACDS; Silva NNT; Carneiro CM; Coura-Vital W; Lima AA
    BMC Public Health; 2020 Mar; 20(1):301. PubMed ID: 32143614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
    Amdisen L; Kristensen ML; Rytter D; Mølbak K; Valentiner-Branth P
    Vaccine; 2018 Sep; 36(38):5747-5753. PubMed ID: 30111513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark.
    Gørtz M; Brewer NT; Hansen PR; Ejrnæs M
    Vaccine; 2020 Jun; 38(28):4432-4439. PubMed ID: 32418796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
    PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
    McClure CA; MacSwain MA; Morrison H; Sanford CJ
    Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
    Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
    Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.
    Spayne J; Hesketh T
    BMJ Open; 2021 Sep; 11(9):e052016. PubMed ID: 34475188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
    Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
    Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.